Tag - membranous nephropathy

From implementing global kidney health commitments to results of the Phase 2 ACTION2 trial: Read the latest ISN Journal summaries  

Kidney International®   Implementing the commitments of the WHO Kidney Health Resolution: Initial steps in three diverse settings  Chronic kidney disease (CKD) affects 850 million people globally, with the highest burden in low- and middle-income countries. The WHA78 kidney health resolution offers a unique opportunity to advance prevention and care.   This editorial presents case studies from Guatemala, Thailand,...

ISN Journal summaries on membranous nephropathy and disaster management

Kidney International® Designing clinical trials for the treatment of membranous nephropathy in the anti-PLA2R era: Results of a NephCure membranous nephropathy workshop Membranous nephropathy (MN) is a leading cause of adult nephrotic syndrome, and anti-PLA2R antibodies are now recognized as key biomarkers reflecting disease activity in many patients. At a 2023 NephCure workshop, experts discussed how to...

Latest ISN Journal Summaries

Kidney International®  Mayo Clinic Consensus Report on Membranous Nephropathy: Proposal for a Novel Classification  This report proposes a two-step classification of membranous nephropathy (MN). Step one is identifying the target antigen based on a multistep algorithm. The second step is the search for a potential underlying disease or associated condition. The meeting consensus favored using an antigen-based...

ISN Journal Editorial Selections

Kidney International® Models of Care to Address Disparities in Kidney Health Outcomes for First Nation People First Nations people in Australia, New Zealand, Canada, and the USA face a higher risk of kidney problems and struggle to get kidney transplants compared to non-Indigenous people. This review identifies studies that created special healthcare programs for First Nations people...